Latest Altitude Crest Partners Inc. Stock Portfolio

$233Million | No. of Holdings #30

Altitude Crest Partners Inc. Performance

2024 Q1+4.09%

YTD+4.09%

About Altitude Crest Partners Inc. and 13F Hedge Fund Stock Holdings

On 2024-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Altitude Crest Partners Inc. reported an equity portfolio of $233.6 Millions as of 31 Mar, 2024. <br><br> The top stock holdings of Altitude Crest Partners Inc. are LEGN, DHR, BBIO. The fund has invested 15.7% of it's portfolio in LEGEND BIOTECH CORP and 11.6% of portfolio in DANAHER CORPORATION. <br><br> The fund managers got completely rid off ARGENX SE (ARGX), BIOMARIN PHARMACEUTICAL INC (BMRN) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in ROIVANT SCIENCES LTD (ROIV), BRIDGEBIO PHARMA INC (BBIO) and KINIKSA PHARMACEUTICALS LTD (KNSA). Altitude Crest Partners Inc. opened new stock positions in STEVANATO GROUP S P A (STVN), THERMO FISHER SCIENTIFIC INC (TMO) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to APELLIS PHARMACEUTICALS INC (APLS) and LEGEND BIOTECH CORP (LEGN).

Altitude Crest Partners Inc. Equity Portfolio Value

Last Reported on: 14 May, 2024

$233Million

as of May 14, 2024

Altitude Crest Partners Inc. Annual Return Estimates Vs S&P 500

Our best estimate is that Altitude Crest Partners Inc. made a return of 4.09% in the last quarter. In trailing 12 months, it's portfolio return was NA%.

Performance
S&P 500

New Buys

Ticker	$ Bought
stevanato group s p a	17,655,000
thermo fisher scientific inc	10,694,300
arrivent biopharma inc	9,922,210
structure therapeutics inc	8,793,420
janux therapeutics inc	7,277,740
eli lilly & co	7,157,230
biohaven ltd	6,474,200
immunome inc	6,473,170

New stocks bought by Altitude Crest Partners Inc.

Additions

Ticker	% Inc.
apellis pharmaceuticals inc	88.75
legend biotech corp	20.47

Additions to existing portfolio by Altitude Crest Partners Inc.

Reductions

Ticker	% Reduced
roivant sciences ltd	-43.72
bridgebio pharma inc	-18.89
kiniksa pharmaceuticals ltd	-12.19
danaher corporation	-10.61

Altitude Crest Partners Inc. reduced stake in above stock

Sold off

Ticker	$ Sold
biomarin pharmaceutical inc	-10,995,900
exact sciences corp	-7,333,640
ambrx biopharma inc	-613,744
argenx se	-11,222,700

Altitude Crest Partners Inc. got rid off the above stocks

Sector Distribution

Altitude Crest Partners Inc. has about 61.3% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	61.3
Others	38.7

Market Cap. Distribution

Altitude Crest Partners Inc. has about 19.2% of it's portfolio invested in the large-cap and mega-cap stocks.

UNALLOCATED
MID-CAP
LARGE-CAP
SMALL-CAP
MEGA-CAP
NANO-CAP

Category	%
UNALLOCATED	38.7
MID-CAP	30.8
LARGE-CAP	11.6
SMALL-CAP	10
MEGA-CAP	7.6
NANO-CAP	1.2

Stocks belong to which Index?

About 44.1% of the stocks held by Altitude Crest Partners Inc. either belong to S&P 500 or RUSSELL 2000 index.

Others
RUSSELL 2000
S&P 500

Index	%
Others	56
RUSSELL 2000	24.8
S&P 500	19.3

Top 5 Winners (%)		%
JANX	janux therapeutics inc	265.2 %
GERN	geron corp	62.6 %
SRZN	surrozen inc	62.5 %
ALGS	aligos therapeutics inc	47.6 %
CRBP	corbus pharmaceuticals hldgs	46.9 %

Top 5 Winners ($)		$
JANX	janux therapeutics inc	5.3 M
DHR	danaher corporation	2.2 M
GERN	geron corp	1.9 M
CRBP	corbus pharmaceuticals hldgs	1.3 M
KNSA	kiniksa pharmaceuticals ltd	1.0 M

Top 5 Losers (%)		%
BBIO	bridgebio pharma inc	-21.8 %
ROIV	roivant sciences ltd	-5.6 %
ALNY	alnylam pharmaceuticals inc	-5.2 %
APLS	apellis pharmaceuticals inc	-4.4 %

Top 5 Losers ($)		$
BBIO	bridgebio pharma inc	-6.7 M
APLS	apellis pharmaceuticals inc	-0.8 M
ROIV	roivant sciences ltd	-0.5 M
ALNY	alnylam pharmaceuticals inc	0.0 M

Altitude Crest Partners Inc. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Altitude Crest Partners Inc.

Altitude Crest Partners Inc. has 30 stocks in it's portfolio. About 69.3% of the portfolio is in top 10 stocks. BBIO proved to be the most loss making stock for the portfolio. JANX was the most profitable stock for Altitude Crest Partners Inc. last quarter.

$233.59MTotal Value

34.00Positions

14 May, 2024Last Reported

Current holdings of Current Stock Holdings of Altitude Crest Partners Inc., last reported on 14 May, 2024. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
AGIO Agios Pharmaceuticals Inc Agios Pharmaceuticals IncAGIO Altitude Crest Partners Inc.'s holding in Agios Pharmaceuticals Inc over time	1.42%	113,100	$3.31M 1.42%	new position

ALGS Aligos Therapeutics Inc Aligos Therapeutics IncALGS Altitude Crest Partners Inc.'s holding in Aligos Therapeutics Inc over time	1.19%	2,844,680	$2.79M 1.19%	unchanged 0 percentunchanged

ALNY Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals IncALNY Altitude Crest Partners Inc.'s holding in Alnylam Pharmaceuticals Inc over time	0.01%	200	$29.9K 0.01%	new position

AMAM Ambrx Biopharma Inc Ambrx Biopharma Inc AMAM Altitude Crest Partners Inc.'s holding in Ambrx Biopharma Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

APLS Apellis Pharmaceuticals Inc Apellis Pharmaceuticals IncAPLS Altitude Crest Partners Inc.'s holding in Apellis Pharmaceuticals Inc over time	7.23%	287,277	$16.89M 7.23%	increased 88.75 percentadded

APLT Applied Therapeutics Inc Applied Therapeutics IncAPLT Altitude Crest Partners Inc.'s holding in Applied Therapeutics Inc over time	0.76%	259,700	$1.77M 0.76%	new position

ARGX Argenx Se Argenx Se ARGX Altitude Crest Partners Inc.'s holding in Argenx Se over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

BBIO Bridgebio Pharma Inc Bridgebio Pharma IncBBIO Altitude Crest Partners Inc.'s holding in Bridgebio Pharma Inc over time	8.1%	612,060	$18.92M 8.1%	decreased 18.89 percentreduced

BMRN Biomarin Pharmaceutical Inc Biomarin Pharmaceutical IncBMRN Altitude Crest Partners Inc.'s holding in Biomarin Pharmaceutical Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

CRBP Corbus Pharmaceuticals Hldgs Corbus Pharmaceuticals HldgsCRBP Altitude Crest Partners Inc.'s holding in Corbus Pharmaceuticals Hldgs over time	1.74%	103,703	$4.07M 1.74%	new position

DAWN Day One Biopharmaceuticals I Day One Biopharmaceuticals IDAWN Altitude Crest Partners Inc.'s holding in Day One Biopharmaceuticals I over time	1.38%	195,497	$3.23M 1.38%	new position

DHR Danaher Corporation Danaher CorporationDHR Altitude Crest Partners Inc.'s holding in Danaher Corporation over time	11.62%	108,700	$27.14M 11.62%	decreased 10.61 percentreduced

DNLI Denali Therapeutics Inc Denali Therapeutics IncDNLI Altitude Crest Partners Inc.'s holding in Denali Therapeutics Inc over time	1.84%	209,613	$4.30M 1.84%	new position

EXAS Exact Sciences Corp Exact Sciences CorpEXAS Altitude Crest Partners Inc.'s holding in Exact Sciences Corp over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

GERN Geron Corp Geron CorpGERN Altitude Crest Partners Inc.'s holding in Geron Corp over time	2.16%	1,531,400	$5.05M 2.16%	new position

ICLR Icon Plc Icon Plc ICLR Altitude Crest Partners Inc.'s holding in Icon Plc over time	2.13%	14,800	$4.97M 2.13%	new position

IMNM Immunome Inc Immunome IncIMNM Altitude Crest Partners Inc.'s holding in Immunome Inc over time	2.77%	262,284	$6.47M 2.77%	new position

JANX Janux Therapeutics Inc Janux Therapeutics IncJANX Altitude Crest Partners Inc.'s holding in Janux Therapeutics Inc over time	3.12%	193,300	$7.28M 3.12%	new position

KNSA Kiniksa Pharmaceuticals Ltd Kiniksa Pharmaceuticals LtdKNSA Altitude Crest Partners Inc.'s holding in Kiniksa Pharmaceuticals Ltd over time	3.38%	400,441	$7.90M 3.38%	decreased 12.19 percentreduced

LEGN Legend Biotech Corp Legend Biotech Corp LEGN Altitude Crest Partners Inc.'s holding in Legend Biotech Corp over time	15.67%	652,732	$36.61M 15.67%	increased 20.47 percentadded